242 related articles for article (PubMed ID: 30629809)
1. Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma.
Siddiqui SH; Siddiqui E; Bavier RD; Patel NM; Kiliç S; Baredes S; Hsueh WD; Eloy JA
Int Forum Allergy Rhinol; 2019 Apr; 9(4):363-369. PubMed ID: 30629809
[TBL] [Abstract][Full Text] [Related]
2. A Population-Based Analysis of Survival for Sinonasal Rhabdomyosarcoma.
Unsal AA; Chung SY; Unsal AB; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):142-149. PubMed ID: 28397540
[TBL] [Abstract][Full Text] [Related]
3. Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes.
Thompson CF; Kim BJ; Lai C; Grogan T; Elashoff D; St John MA; Wang MB
Int Forum Allergy Rhinol; 2013 Aug; 3(8):678-83. PubMed ID: 23424037
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
Lo WL; Huang WH; Yeh CF
In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in Adult Sinonasal Rhabdomyosarcoma.
Stepan K; Konuthula N; Khan M; Parasher A; Del Signore A; Govindaraj S; Genden E; Iloreta A
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):135-141. PubMed ID: 28669309
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
7. Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study.
Durzynska M; Dos Santos FLC; Michalek IM
Anticancer Res; 2023 Oct; 43(10):4517-4524. PubMed ID: 37772581
[TBL] [Abstract][Full Text] [Related]
8. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series.
Li W; Lu H; Wang D
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2793-2802. PubMed ID: 31444550
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
[TBL] [Abstract][Full Text] [Related]
11. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
[TBL] [Abstract][Full Text] [Related]
12. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in sinonasal sarcomas: analysis of the surveillance, epidemiology and end result database.
Wu AW; Suh JD; Metson R; Wang MB
Laryngoscope; 2012 Oct; 122(10):2137-42. PubMed ID: 22777866
[TBL] [Abstract][Full Text] [Related]
14. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
Roy S; Pathy S; Mohanti BK; Chander S; Biswas A
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e62-e68. PubMed ID: 28060113
[TBL] [Abstract][Full Text] [Related]
15. Staging and survival for sinus cancer in the pediatric population.
Shapiro NL; Bhattacharyya N
Int J Pediatr Otorhinolaryngol; 2009 Nov; 73(11):1568-71. PubMed ID: 19720405
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy analysis of adult sinonasal rhabdomyosarcoma].
Bai Y; Chen X; Yan Y; Zhang S; Zhou W; Fang J; Huang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(9):804-10. PubMed ID: 26281056
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
19. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
20. Management of paediatric sinonasal rhabdomyosarcoma.
Fyrmpas G; Wurm J; Athanassiadou F; Papageorgiou T; Beck JD; Iro H; Constantinidis J
J Laryngol Otol; 2009 Sep; 123(9):990-6. PubMed ID: 19393123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
